Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
Authors:
Open Access
- 20 September 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 11, 335
Abstract
In the past 4 years, many publications described a concentration-dependent deposition of gadolinium in the brain both in adults and children, seen as high signal intensities in the globus pallidus and dentate nucleus on unenhanced T1-weighted images. Postmortem human or animal studies have validated gadolinium deposition in these T1-hyperintensity areas, raising new concerns on the safety of gadolinium-based contrast agents (GBCAs). Residual gadolinium is deposited not only in brain, but also in extracranial tissues such as liver, skin, and bone. This review summarizes the current evidence on gadolinium deposition in the human and animal bodies, evaluates the effects of different types of GBCAs on the gadolinium deposition, introduces the possible entrance or clearance mechanism of the gadolinium and potential side effects that may be related to the gadolinium deposition on human or animals, and puts forward some suggestions for further research.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 67 references indexed in Scilit:
- High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast MaterialRadiology, 2014
- Intracranial Lesions with High Signal Intensity on T1-weighted MR Images: Differential DiagnosisRadioGraphics, 2012
- Incidence of Immediate Gadolinium Contrast Media ReactionsAmerican Journal of Roentgenology, 2011
- Hyperintense Dentate Nucleus on Unenhanced T1-weighted MR Images Is Associated with a History of Brain IrradiationRadiology, 2011
- Multiple Sclerosis: Hyperintense Dentate Nucleus on Unenhanced T1-weighted MR Images Is Associated with the Secondary Progressive SubtypeRadiology, 2009
- Incorporation of excess gadolinium into human bone from medical contrast agentsMetallomics, 2009
- Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°CInvestigative Radiology, 2008
- MR Imaging Findings in Hepatic EncephalopathyAmerican Journal of Neuroradiology, 2008
- Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass SpectroscopyInvestigative Radiology, 2006
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984